Workflow
启明医疗核心产品
icon
Search documents
启明医疗-B(02500.HK)中期母公司拥有人应占亏损1.35亿元
Ge Long Hui· 2025-08-28 13:45
Core Viewpoint - The company reported a significant decline in revenue for the first half of 2025, primarily due to a decrease in product pricing driven by market competition and a shift in sales strategy [1] Revenue Performance - The company's revenue for the six months ending June 30, 2025, was RMB 187.1 million, representing an 18.9% year-on-year decrease [1] - The decline in revenue is attributed to two main factors: intense market competition leading to a strategic pricing adjustment, and a transition from a direct sales model to a platform sales model [1] Profitability - The loss attributable to equity holders of the parent company was RMB 135 million, compared to a loss of RMB 206 million in the same period last year [1]